MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q3
hinzugefügt 01.11.2023
Seagen ROE 2011-2025 | SGEN
ROE Jährlich Seagen
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.77 | -22.0 | 17.59 | -8.46 | -17.48 | -18.53 | -22.1 | -17.57 | -36.11 | -27.16 | -23.78 | -69.47 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 17.59 | -69.47 | -22.24 |
ROE Vierteljährlich Seagen
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29.72 | -28.02 | -24.54 | -15.91 | -25.2 | -27.72 | -25.61 | -15.32 | -10.53 | 16.99 | 18.88 | 17.59 | 14.18 | -8.96 | -12.57 | -8.46 | -19.24 | -19.63 | -9.42 | -17.48 | -16.81 | -4.14 | -18.44 | -18.53 | -18.48 | -30.87 | -27.72 | -22.1 | -17.02 | -15.87 | -17.63 | -17.57 | -26.6 | -30.13 | -31.54 | -36.11 | -30.27 | -33.17 | -27.83 | -27.16 | -25.04 | -20.78 | -25.41 | -23.78 | -31.51 | -44.06 | -59.98 | -69.47 | -18.59 | -23.53 | -14.93 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 18.88 | -69.47 | -20.7 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
-68.71 | $ 4.95 | 4.99 % | $ 822 M |  Canada |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
-84.9 | $ 3.2 | -1.48 % | $ 247 M |  USA |
 |
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | USA |
 |
Aptevo Therapeutics
APVO
|
-507.47 | $ 1.06 | -5.97 % | $ 293 K | USA |
 |
Catalyst Biosciences
CBIO
|
540.06 | $ 13.19 | -6.39 % | $ 868 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
-43.41 | $ 213.99 | -2.92 % | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.1 | -5.93 % | $ 7.46 B |  Australia |
 |
Celldex Therapeutics
CLDX
|
-21.13 | $ 27.04 | -1.73 % | $ 1.74 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
20.78 | $ 87.29 | -0.8 % | $ 9.01 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
22.52 | $ 24.46 | 3.56 % | $ 2.9 B | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | $ 5.04 | -0.3 % | $ 938 M | Germany |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
BioVie
BIVI
|
-92.27 | $ 1.43 | -1.38 % | $ 2.11 M | USA |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
4.58 | $ 10.87 | 0.63 % | $ 1.41 B | USA |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
1.11 | $ 94.19 | -0.66 % | $ 27.2 B | Germany |
 |
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
21.78 | $ 26.28 | 4.0 % | $ 1.27 B | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
-38.95 | $ 9.64 | 0.84 % | $ 141 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-6.05 | $ 15.96 | -4.43 % | $ 409 M | USA |
 |
Evogene Ltd.
EVGN
|
-41.09 | $ 1.05 | -2.78 % | $ 27.9 M |  Israel |
 |
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 0.27 | -6.29 % | $ 588 M | Israel |
|
Foghorn Therapeutics
FHTX
|
190.26 | $ 4.39 | -1.13 % | $ 241 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-531.22 | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
16.2 | $ 548.77 | -2.75 % | $ 41.6 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.36 | 2.61 % | $ 14.8 M | USA |
 |
AstraZeneca PLC
AZN
|
20.44 | $ 91.51 | 1.87 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
10.1 | $ 8.95 | -0.56 % | $ 1.45 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
-19.35 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
114.5 | $ 11.28 | -2.17 % | $ 730 M | USA |
 |
Biogen
BIIB
|
9.76 | $ 174.19 | 0.05 % | $ 25.4 B | USA |
 |
Abeona Therapeutics
ABEO
|
-365.49 | $ 5.07 | -5.5 % | $ 108 M | USA |